US FDA stelt handhaving DSCSA Product Identifier uit

31 augustus 2017

FDA issued a draft guidance for industry, Product Identifier Requirements Under the Drug Supply Chain Security Act – Compliance Policy. This guidance informs manufacturers and other supply chain stakeholders that although manufacturers are to begin including a product identifier on prescription drug packages and cases on November 27, 2017, the FDA is delaying enforcement of those requirements until November 2018 to provide manufacturers with additional time. The compliance policy outlined in the draft guidance applies solely to products without a product identifier that are introduced into commerce by a manufacturer between November 27, 2017 and November 26, 2018 (US FDA, 30 juni 2017).
Klik hier voor de mededeling van de FDA.
Klik hier om de draft guidance for industry te downloaden (100 kB).
Klik hier voor meer informatie over het NVC-project Pharmaceutical Packaging Innovation.
Klik hier voor meer informatie over de NVC E-Course Pharmaceutical Packaging.

Dit bericht is ook opgenomen in ons maandelijkse nieuwsoverzicht, de NVC Members-only Update. Heeft u vragen, neem dan contact met ons op via e-mail of bel: +31-(0)182-512411.